Product:
Sells a kit for the diagnosis of lactose intolerance. LacTEST® is administered to the patient, and the lab uses Xylossay® kit for the quantification of the intolerance to lactose.
Advantage:
Other tests require the patients to take an “overdose” of Lactose which creates discomfort for days. LacTest uses an equivalent substance which is inert to the
body and gives more accurate results with no side effects Standard laboratory equipment and procedures required to use the kits.
body and gives more accurate results with no side effects Standard laboratory equipment and procedures required to use the kits.
Market opportunity:
Lactose intolerance affects around 38% of people of white descent and 75% of Asian, North and South American native populations and sub-Saharan ancestry, to a global of 65% of the world population. Three Million tests are currently performed in EU, USA and Russia per year.
Commercial Status
Intellectual Property
US patents granted
Tested in humans?
clinical validation done
FDA approval?
Exp. 3Q-2021
CE approval?
Spain 2013
US reimbursement?
Not expected
EU reimbursement?
Spain 2012; others in process
Currently selling?
Spain.
Mexico exp. 2018.
Mexico exp. 2018.
links of interest
